This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chernesky, M.
Right arrow Articles by Kapala, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chernesky, M.
Right arrow Articles by Kapala, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2001, p. 2306-2307, Vol. 39, No. 6
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.6.2306-2307.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Comparison of a Polymer Conjugate-Enhanced Enzyme Immunoassay to Ligase Chain Reaction for Diagnosis of Chlamydia trachomatis in Endocervical Swabs

Max Chernesky,1,* Dan Jang,1 Debby Copes,2 Jay Patel,3 Astrid Petrich,1 Kathleen Biers,3 Arlene Sproston,3 and Julius Kapala3

McMaster University and St. Joseph's Hospital, Hamilton,1 Choice in Health Clinic, Toronto,2 and Gamma-Dynacare Medical Laboratories, Brampton,3 Ontario, Canada

Received 20 December 2000/Returned for modification 6 March 2001/Accepted 21 March 2001

Two endocervical swabs from each of 1,123 women were collected into manufacturer-supplied transport tubes and tested for Chlamydia trachomatis by a polymer conjugate-enhanced (PCE) enzyme immunoassay (EIA) (IDEIA PCE Chlamydia; DAKO) and a ligase chain reaction assay (LCx Chlamydia; Abbott). After confirmation by the EIA blocking test, the sensitivity of the IDEIA PCE remained at 91.8% and the specificity increased from 98.2 to 99.8% compared to LCx.


* Corresponding author. Mailing address: Medical Microbiology Service, St. Joseph's Hospital, 50 Charlton Ave. East, Room L424, Hamilton, Ontario L8N 4A6, Canada. Phone: (905) 521-6021. Fax: (905) 521-6083. E-mail: chernesk{at}mcmaster.ca.


Journal of Clinical Microbiology, June 2001, p. 2306-2307, Vol. 39, No. 6
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.6.2306-2307.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Fadel, S., Eley, A. (2008). Is lipopolysaccharide a factor in infectivity of Chlamydia trachomatis?. J Med Microbiol 57: 261-266 [Abstract] [Full Text]  
  • Horner, P., Skidmore, S., Herring, A., Sell, J., Paul, I., Caul, O., Egger, M., McCarthy, A., Sanford, E., Salisbury, C., MacLeod, J., Sterne, J., Low, N., for the Chlamydia Screening Studies (ClaSS) Group, (2005). Enhanced Enzyme Immunoassay with Negative-Gray-Zone Testing Compared to a Single Nucleic Acid Amplification Technique for Community-Based Chlamydial Screening of Men. J. Clin. Microbiol. 43: 2065-2069 [Abstract] [Full Text]  
  • Solomon, A. W., Peeling, R. W., Foster, A., Mabey, D. C. W. (2004). Diagnosis and Assessment of Trachoma. Clin. Microbiol. Rev. 17: 982-1011 [Abstract] [Full Text]  
  • Chernesky, M A (2002). Chlamydia trachomatis diagnostics. Sex. Transm. Infect. 78: 232-234 [Abstract] [Full Text]